Bromide

Bromide

SCHEMBL1032276

Br.Br.Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL116499 1.00
Bromide SCHEMBL1029370 1.00
Bromide SCHEMBL1031102 1.00
Bromide SCHEMBL2581411 1.00
Bromide SCHEMBL1030524 1.00
Bromide SCHEMBL11503584 1.00
Bromide SCHEMBL1025982 1.00
Bromide SCHEMBL10427946 1.00
Bromide SCHEMBL10457047 1.00
Bromide SCHEMBL30602641 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384789-B2 Compounds for treating Huntington's disease PTC THERAPEUTICS, INC. (US) 2025-08-12 US claimed
CN-111065626-B Compounds for the treatment of huntington's disease PTC医疗公司 2024-09-27 CN claimed
CN-113768873-B Fuhexine lipid nanosuspension and preparation method thereof 山东师范大学 2023-05-05 CN claimed
EP-4151627-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2023-03-22 EP claimed
US-20220251098-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC THERAPEUTICS, INC. 2022-08-11 US claimed
US-8067108-B1 Hybrid battery for use over extended temperature range ELECTROCHEM SOLUTIONS, INC. (US) 2011-11-29 US claimed
CN-1196732-A Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors SEARLE & CO (US) 1998-10-21 CN claimed
EP-0111214-B1 NONAQUEOUS CELL AND A METHOD FOR TREATING AN ACTIVE METAL ANODE OF A NONAQUEOUS CELL EVEREADY BATTERY COMPANY, INC. (US) 1988-01-27 EP claimed
US-4654280-A AND VINYL HALIDE POLYMER, PREVENTS INITIAL VOLTAGE DELAY EVEREADY BATTERY COMPANY (US) 1987-03-31 US claimed
EP-0186200-A2 Nonaqueous cell employing a cathode-electrolyte solution containing a boron-containing additive EVEREADY BATTERY COMPANY, INC. (US) 1986-07-02 EP claimed
US-4516317-A HIGH ENERGY BATTERIES UNION CARBIDE CORPORATION (US) 1985-05-14 US claimed
EP-0111214-A2 Nonaqueous cell and a method for treating an active metal anode of a nonaqueous cell EVEREADY BATTERY COMPANY, INC. (US) 1984-06-20 EP claimed
US-4444855-A HALIDE SOLVENT UNION CARBIDE CORPORATION (US) 1984-04-24 US claimed
US-4440836-A TO PREVENT EXCESSIVE PASSIVATION UNION CARBIDE CORPORATION (US) 1984-04-03 US claimed
EP-4626866-A1 NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF Assia Chemical Industries Ltd. (IL) 2025-10-08 EP disclosed
WO-2025202445-A2 CXCR4 INHIBITOR COMPOUND IN THE TREATMENT AND/OR THE PREVENTION OF SEVERE ARDS 4LIVING BIOTECH (FR) 2025-10-02 WO disclosed
US-20250223485-A1 WELLBORE FLUIDS INCLUDING SHALE INHIBITORS, AND RELATED METHODS SCHLUMBERGER TECHNOLOGY CORPORATION 2025-07-10 US disclosed
US-4032696-A ELECTROCHEMISTRY UNION CARBIDE CORPORATION (US) 1977-06-28 US disclosed
US-3985573-A Slotted cathode collector bobbin for use in liquid cathode cell systems UNION CARBIDE CORPORATION (US) 1976-10-12 US disclosed
US-3984718-A Gas discharge dielectric containing germanium or tin OWENS-ILLINOIS, INC. (US) 1976-10-05 US disclosed